ABSTRACT
INTRODUCTION
Microarray experiments typically measure the expression levels of several thousands of genes simultaneously. In cDNA data, it is common to have a large number of genes and a relatively small sample size. By removing redundant variables (genes), it would be possible to highlight those genes that are most relevant for certain events (for instance, certain diseases or a certain type of tumor).
Several approaches for finding the differentially expressed genes have been proposed: the t-test (e.g. Devore and Peck, 1997) , a regression modeling approach (Thomas et al., 2001) , mixture model approach (Pan, 2002) and non-parametric methods (Troyanskaya et al., 2002) . All of these are univariate gene selection methods and hence suffer from the fact that no correlations between the genes are considered in the selection procedure. Recently, Lee et al. (2003) developed a multivariate Bayesian model to perform variable selection. Their method made use of mixture prior distribution, which is very sensitive toward the choice of some hyper-parameters like the mixing probability π. In general, the algorithm is * To whom correspondence should be addressed. slow due to complicated mixing structure of the posterior distribution.
From a machine learning viewpoint, high dimensionality and sparsity of data points suggest the use of support vector machines (SVMs) (Campbell, 2002) . Usually SVMs achieve low test error despite small sample sizes. Several papers have reported results on the application of SVMs for performing variable selection (Guyon et al., 2002; Weston et al., 2001) . However, this method has a number of disadvantages, such as the absence of probabilistic output and the necessity of estimating a trade-off parameter in order to utilize Mercer kernel functions. An alternative approach is to exploit the Bayesian technique of automatic relevance determination (ARD). An ARD approach has been used previously for constructing a sparse classifier using the relevance vector machine (RVM) of Tipping (2000 Tipping ( , 2001 . Li et al. (2002) utilized ARD to perform variable selection rather than using generalization bounds from statistical learning theory. Their variable selection method has a performance similar to SVMs when applied to gene expression datasets from cDNA microarray data. The advantage of their approach is that variable sparsity is naturally incorporated into the algorithm-the optimal number of relevant variables is decided automatically. In contrast, for an SVM an additional variable selection procedure has to be added and a further criterion must be used to indicate when the best variable set has been found. In terms of practical application, Li et al. (2002) highlight the importance of a small number of influential genes. They use a zero-mean Gaussian prior with unknown variance for the unknown regression parameter β that favors sparseness in estimating β. This choice of prior for β shows very good performances (Williams, 1998; Williams and Barber, 1998) but the main disadvantage is that it does not control the structural complexity of the resulting functions. That is, if one of the components of β happens to be irrelevant, a Gaussian prior will not set it exactly to zero but instead to some small value (shrinkage rather than selection).
In this paper, we consider a multivariate Bayesian regression model and assign priors that favor sparseness in terms of number of variables (genes) used. We introduce the use of different priors to promote different degrees of sparseness using a unified two-level hierarchical Bayesian model. In our first model, we assign a zero-mean Gaussian prior to β with an independent prior distribution for the unknown variance of β. This model is related to ARD, although we perform full Bayesian analysis rather than marginal-likelihood maximization. We use a Laplace prior in our second model as it is known to promote sparseness (Williams, 1995) , which is equivalent to the Lasso model. Our third model is based on the noninformative Jeffreys prior suggested by Figueiredo (2001) . This particular prior does not contain any hyper-parameter by which we can implement variable selection automatically as well as strongly induce sparseness in the model. Importantly, the number of selected genes is decided automatically. Unlike other approaches, which are based on approximations, we will perform full Bayesian analysis exploiting simulation based on Markov chain Monte Carlo (MCMC) methodology (Gelfand and Smith, 1990; Gilks et al., 1996) to derive the estimates (as well as the uncertainty distributions) of the unknown parameters.
We apply our methods to a leukemia dataset from Golub et al. (1999) and also to a dataset from Hendenfalk et al. (2001) . The idea is to identify a small number of genes having the greatest discriminating power, thereby allowing researchers to quickly focus on the most promising candidates for diagnostics and therapeutics.
MODEL
Suppose that n independent binary random variables (e.g. normal and cancer), Y 1 , . . . , Y n are observed. Y i = 1 indicates that sample i is cancer or one type of cancer (e.g. ALL, BRCA1) and Y i = 0 indicates that sample i is normal or the other type of cancer (e.g. AML, BRCA2 and sporadic). For each sample, we measure gene expression levels for a set. Let X ij denote the gene expression level of the j -th gene for the i-th sample and we form the data matrix X as
Define the binary regression model as
where β is the vector of unknown regression parameters, X i is the i-th row vector of the matrix X and is the standard normal cumulative density function linking the probability p i with the linear structure X i β. This is known as probit model. Albert and Chib (1993) introduce n independent latent variables Z = (Z i , . . . , Z n ) into the problem, where We consider different priors for β in a two-level hierarchical Bayesian model. This model involves a zero-mean Gaussian prior for β with unknown variances. Then, we assign choices of priors for the variances assuming that they are independent. So, the prior distribution of β is β| ∼ N(0, ), where 0 = (0, . . . , 0) , = diag(λ 1 , . . . , λ p ) and λ i is the variance of β i . We assign three different choices of prior distributions for which develop three different models inducing different degrees of sparsity to select the number of genes used.
Prior distribution for the
For Model I, we assign a conjugate Inverse Gamma prior for each λ i in as IG(a/2, 2/b). Here a random variable X is said to follow Inverse Gamma distribution if IG
. Note that we have two hyper-parameters, a and b, to be adjusted. Usually we adjust a and b in such a way that the variance of λ is very large. This model is equivalent to ARD model of Li et al. (2002) . Assuming independence among λ i s, the prior distribution of is given by
In Model II, we assign a Laplace prior for β to promote sparseness (so that irrelevant parameters are set exactly to zero). We can express the Laplace prior distribution as a scale mixture of Normal priors, which is equivalent to a two-level hierarchical Bayesian model. The Laplace prior can be expressed as a zero-mean Gaussian prior with an independent exponentially distributed variance:
We assign an exponential distribution for the prior distribution of λ i , which is equivalent to assigning a Laplace prior for β.
Here, a random variable X is said to follow exponential distribution with parameter γ denoted as expon(γ ) and expressed
2 . The prior distribution of (again with the assumption of independence among λ i ) is given by
Here again we need to fix the hyper-parameter γ in such a way that the variance of λ is high. This is similar to the Lasso model but has added flexibility due to the choices of multiple λs as against one choice in the Lasso method.
In Model III, we attempt to avoid the problem of fixing the hyper-parameters by letting the prior distribution of be a non-informative Jeffreys prior as
As already shown in Figueiredo (2001) and in our experimental results, this prior strongly induces sparseness and yields good performance.
COMPUTATION
The posterior distribution is not available in explicit form so we use the MCMC method (Gilks et al., 1996) , specifically Gibbs sampling (Gelfand and Smith, 1990) to simulate the parameters from the posterior distribution. The full conditional distribution of Z has a truncated normal distribution. The random variables Z 1 , . . . , Z n are independent with
We generate random numbers Z i using Robert's (1995) optimal exponential accept-reject algorithm.
In the two-level hierarchical Bayesian model with zeromean Gaussian priors and independently distributed variances for β, the full conditional distribution of β is as follows.
where, = (X X + −1 ) −1 . We have used the WoodburySherman-Morrison matrix identity to reduce the dimension of the matrix, from p to n. This makes the computation much faster because we have cDNA data which has a high dimensionality corresponding to the small sample (n << p).
The full conditional distribution of for the Inverse Gamma prior (Model I) is the following:
The full conditional distribution of for the exponential prior (Model II) is the following:
where InvGauss denotes the inverse Gaussian distribution. The inverse Gaussian distribution for a random variable X is expressed as
We use the algorithm of Michael et al. (1976) to generate the random number from the inverse Gaussian distribution.
The full conditional distribution of with the Jeffreys prior (Model III) is the following:
where G is the Gamma distribution.
In practice, many of the λ i approach zero, implying those genes can be pruned from the model. During MCMC iteration we delete genes using the criterion λ i < 10 −12 as in Li et al. (2002) . Also we re-introduce a gene which has been eliminated if it has large enough variance (10 or more). However, we found little change in performance on varying this re-introduction bound.
Finally, we obtain the predictive classification of a new observation Y new , conditioning on the gene expression level X using the Monte-Carlo estimate:
where β t , Z t , and t are the MCMC samples from the posterior distribution.
APPLICATION OF GENE SELECTION Leukemia dataset
We apply our method to the Leukemia dataset that has been extensively studied by Golub et al. (1999) . The authors gathered bone marrow or peripheral blood samples from 72 patients with either acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL). The data are split into a training set consisting of 38 samples of which 27 are ALL and 11 are AML, and a test set of 34 samples, 20 ALL and 14 AML. The gene expression levels for 7129 human genes are produced. Golub et al. (1999) investigated the use of a weighted voting scheme on the training samples and correctly classified 36 of the 38 training samples and also correctly classified 29 of the 34 test sample, failing to predict correctly on 5. Using Golub's training data, we identify the 500 most significant genes by using two sample t-test statistics. We start with the 500 genes out of 7129, which include all the significant genes identified by Lee et al. (2003) and Li et al. (2002) . We run the MCMC sampler (in our case, Gibbs sampling with 50 000 iterations and 20 000 burn-in). The priors are as follows. We assume E(λ i ) = 10 and var(λ i ) = 100 a priori for Models I and II and fix the hyper-parameters in that way. We obtain samples from the marginal posterior distribution and obtain the estimates for β i s and λ i s. We plot the absolute values of β i in Figure 1 . The sparseness of β i has been seen significantly in Model III and we can also see that absolute values of β i in Model I are usually bigger than those in Model II.
We select genes using the posterior variance of β while keeping in mind that variables with smaller variance will have no effect and should be excluded from the model. Figure 2 shows the variance of β i for each model. We can identify the genes having significantly larger variances than the others. Both Models I and II contain 20 genes which have significantly larger variance than the others. For Models I and II, we use these genes to perform prediction on the test data. The results are in Table 1 (we not only predict the correct classification but also the probability related to it). There are two misclassifications (5th and 6th) by both Models I and II. The top four selected genes are common to both of them: Zyxin (which encodes a LIM domain protein localized at focal contacts in adherent erythroleukemia cells; Maccalma et al., 1996) ; cell division control related protein (hCDCrel-1) mRNA (which is a partner gene of MLL in some Leukemias; Osaka et al., 1999) ; HoxA9 mRNA (which collaborates with other genes to produce highly aggressive acute leukemia disease; Thorsteinsdottr et al., 1999) and MacMarcks (this gene transcription is stimulated rapidly by tumor necrosis factor-α in human promyelocytic leukemia cells (Harlan et al., 1991) .
In Model III, only Zyxin is selected due to significantly larger variance than others. Zyxin has the third and second rank according to Models I and II, respectively. The selected Zyxin is also one of leading genes in Lee et al. (2003) and Golub et al. (1999) . Our prediction result based on Model III is in Table 1 , which shows that there are three misclassifications using only one gene. Golub et al. (1999) used 50 genes to predict and had five misclassifications on test data. These results appear to improve predictions done by Golub et al. (1999) , having fewer misclassifications while also using fewer genes.
In these small data and high-dimensional problems, several models can fit the data well, each using a distinct set of genes. To investigate the issue, Li et al. (2002) randomly partition the data into two disjoint subsets of equal size and fit the model on both sets. After training they match the common number of genes to both models. These data are heterogeneous as all 38 training samples were obtained from adult bone marrow; some test samples came from peripheral blood or pediatric patients. This type of random partitioning and resampling of the data will make the data more homogeneous (Smith et al., 2002) . Following this idea, we make new training and test datasets by randomly splitting the 72 samples in half (36 + 36 samples). We perform 50 re-samplings and select the top 20 genes. The top 20 selected genes for all the three models were in common at least 24% of times in the re-sampling results. The top four genes for Models I and II were in common 50-70% of times. For Model III, we found Zyxin was in common 80% of times.
These data are not very homogeneous as observations were taken from different cells and to control the variability we re-analyze on a subcategory of the data. For example, ALL cells can be either T-cells or B-cells and we apply this method to determine genes which are likely to be differentially expressed between ALL T-cells and ALL B-cells (Yeoh et al., 2002) . In this manner, we controlled the heterogeneity of the sample type as much as possible by focusing on the B-cells and the T-cells experiments within the ALL group. This gives two reasonably homogeneous sample types, for which we still have many observations. We use 38 samples as training dataset and use the 9 samples as the test dataset, which is the same procedure as that of Grant et al. (2002) . The top four selected genes in Model I are ID 6855, 5542, 1882 and 1962. The top selected gene, ID 6855 is TCF-3 transcription factors (E2A immunoglobulin enhancer binding factors E12/E4. Heterodimers between TCF3 and tissue-specific basic helixloop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, such as muscle or early B-cell differentiation (Kamps et al., 1990) . They are involved in a form of pre-B-cell acute lymphoblastic leukemia (B-ALL) through a chromosomal translocation which involves PBX1 and TCF3. T-cell Antigen CD7 precursor (ID 5542), is one of two common selected genes by Dudoit et al. (2000) and Grant et al. (2002) . The top four genes selected by Model II are ID 6967, 1882, 6855 and 4342. The top selected gene, ID 6967 is SELL Leukocyte adhesion protein beta subunit (ITGB2). The ITGB2 protein product is the integrin-β chain β2. Integrins are integral cell-surface proteins composed of an α-chain and a β-chain. A given chain may combine with multiple partners resulting in different integrins. For example, β2 combines with the αL chain to form the integrin LFA-1, and combines with the αM chain to form the integrin Mac-1. Integrins are known to participate in cell adhesion as well as cell-surface-mediated signaling. The gene TCF7 transcription factor 7 (T-cell specific) (clone ID 4342) is selected by the Model III. This gene is one of the two common selected genes by Dudoit et al. (2000) and Grant et al. (2002) . The Tcf7 gene encodes a transcription factor that is a member of the high mobility group protein family. Expression of Tcf7 is specific to T-cells, and the gene product was originally designated TCF-1, as a T-cellspecific transcription factor. A closely related factor, LEF-1 (lymphocyte transcription factor) is expressed in both T-and B-cell lineages. Both TCF-1 and LEF-1 arise from the same gene, Tcf7, by alternative splicing and the use of dual promoters (Kingsmore et al., 1995) . The detailed results of the analyses are in the Supplementary website.
Hereditary breast cancer dataset
As a second study we also apply our method to a breast cancer dataset (Hendenfalk et al., 2001 ) from patients carrying mutations in the predisposing genes, BRCA1 or BRCA2 or from patients not expected to carry a hereditary predisposing mutation. Pathological and genetic differences appear to imply different but overlapping functions for BRCA1 and BRCA2. Hendenfalk et al. (2001) examined 22 breast tumor samples from 21 breast cancer patients. A total of 15 women had hereditary cancer, 7 having tumors with BRCA1 and 8 having tumors with BRCA2. A total of 3226 genes were used for each breast tumor sample. We use our method to classify BRCA1 versus the others (BRCA2 and sporadic). We used initial two-sample t-test statistics to identify the 500 most significant genes and run the MCMC sampler as in the previous example. We chose the same hyper-parameters as in the previous example. The variances of 500 genes are plotted in Figure 3 . Some of the leading genes selected by these approaches appear among the 10 strongest genes in the list in Kim et al. (2002) and Lee et al. (2003) . For both Models I and II, we selected 25 genes which have significantly larger variances than others. The leading gene (by both the approaches) is keartin8 (KRT8), a member of the cytokeratin family of genes. Cytokeratins are frequently used to identify breast cancer metastases by immunohistochemistry, and cytokeratin8 abundance has been shown to correlate well with node-positive disease (Brotherick et al., 1998) . Another top selected gene is tumor-associated antigen L-6 (TM4SF1), a member of a family of integral membrane proteins, several of which are also overexpressed in tumors (Marken et al., 1992) . Antigen L-6 is frequently overexpressed in carcinomas, and antibody binding to L-6 on tumors in nude mouse models inhibits their outgrowth (Hellstrom et al., 1986) .
In Model III, only four genes appeared to be the selected ones with significantly high variance. Keratin 8 and TM4SF1 are the top leading genes in Kim et al. (2002) and Lee et al. (2003) as well as in our previous two models. The other two genes are TOB1 and CTP syntheses which also appeared in all the previously mentioned lists. The gene TOB1 interacts with the oncogene receptor ERBB2, and is found to be more highly expressed in BRCA2 and sporadic cancers, which are likewise more likely to harbor ERBB3 gene amplifications. TOB1 has an anti-proliferative activity that is apparently antagonized by ERBB2 (Matsuda et al., 1996) .
We have checked the sensitivity (stability) of our analysis by adding a Gaussian noise to the expression values as in Lee et al. (2003) . We re-analyzed the data contaminated by Gaussian noise to obtain the newly selected genes and have reproduced the results in Supplementary website. The table shows that the analysis is quite stable, as it is selecting almost similar genes with a different noise level over the expression values.
We also check the model adequacy by leave-one-out cross-validation (CV). We exclude a single data point and predict the P (Y = 1|X) for that data point using Equation (1). For Models I and II, we use the 25 selected genes and for Model III the 3 selected genes to perform the CV. We compare the result of this CV with the observed response. Our CV results are reported in the Supplementary website. There are no misclassifications by Models I and II and two misclassifications (17th and 18th sample) by Model III. We compare our CV results with other popular classification algorithms in Table 2 . All other methods have used 51 genes. It is clear from the results that our methods improve the classification accuracy, having fewer misclassifications while also using fewer genes.
DISCUSSION
We propose two-level hierarchical Bayesian models for variable selection which assume priors favoring sparseness in parameters. We employ latent variables to specialize the model to a regression model. We use simulation-based MCMC methodology to derive the estimates of the unknown parameters. All the three models provide good performance in terms of gene selection but Model III based on Jeffreys prior is preferable as there is no need to specify the hyperparameter or any type of threshold values. Simpler methods based on scores such as Fisher score or correlation coefficients can be used for gene selection but usually they would select a much larger number of genes and due to small sample size the method may produce instability in the classification process. Due to Bayesian setup, we have a coherent way to predict (assign) new samples to particular categories. Rather than hard rules (in or out) of assignment, we can evaluate the probability (chance) that the new sample will be in one of the categories which is more helpful for decision making. Also use of smaller number of important genes simplifies the experimental procedure. Our gene selection method is based on the posterior mean of λ. We use informal, exploratory plots to find the genes with significantly large value of λ. A formal choice of cut-off value to select significant λ based on posterior or predictive criteria will be a topic of future research.
All through our analysis, we assume data are independent and consider only binary classifiers. Future research will consider the gene with interaction situations and extend the analysis to multi-category models.
